Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial | Zendy

Kathleen Mulligan | Zendy; David V. Glidden | Zendy; Peter L. Anderson | Zendy; Albert Liu | Zendy; Vanessa McMahan | Zendy; Pedro Gonzáles | Zendy; Maria Esther Ramirez-Cardich | Zendy; Siriag Namwongprom | Zendy; Piotr Chodacki | Zendy; Laura Maria Carvalo de Mendonca | Zendy; Furong Wang | Zendy; Javier R. Lama | Zendy; Suwat Chariyalertsak | Zendy; Juan V. Guanira | Zendy; Susan Buchbinder | Zendy; LindaGail Bekker | Zendy; Mauro Schechter | Zendy; Valdiléa G. Veloso | Zendy; Robert M. Grant | Zendy

Open Access

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

Author(s) -

Kathleen Mulligan,

David V. Glidden,

Peter L. Anderson,

Albert Liu,

Vanessa McMahan,

Pedro Gonzáles,

Maria Esther Ramirez-Cardich,

Siriag Namwongprom,

Piotr Chodacki,

Laura Maria Carvalo de Mendonca,

Furong Wang,

Javier R. Lama,

Suwat Chariyalertsak,

Juan V. Guanira,

Susan Buchbinder,

LindaGail Bekker,

Mauro Schechter,

Valdiléa G. Veloso,

Robert M. Grant

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ324

Subject(s) - medicine , emtricitabine , placebo , bone mineral , randomized controlled trial , discontinuation , confidence interval , human immunodeficiency virus (hiv) , osteoporosis , viral load , immunology , antiretroviral therapy , alternative medicine , pathology

Daily preexposure prophylaxis (PrEP) with oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) decreases the risk of human immunodeficiency virus (HIV) acquisition. Initiation of TDF decreases bone mineral density (BMD) in HIV-infected people. We report the effect of FTC/TDF on BMD in HIV-seronegative men who have sex with men and in transgender women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research